Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia

Lookup NU author(s): Professor Raj KalariaORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background: Postsynaptic cholinergic deficits, including reduced cortical muscarinic M1 receptor coupling to G-proteins, are neurochemical findings postulated to underlie the limited efficacy of presynaptically-targeted cholinergic replacement therapies in Alzheimer's disease (AD). While the loss of M1-G-protein coupling has been associated with beta-amyloid (A beta) burden in AD, the status of M1 coupling to G-proteins in Parkinson's disease-related or mixed dementias is unclear.Objective: To test the hypothesis that M1 receptor uncoupling is correlated with A beta burden, we aimed to study muscarinic M1 neurochemical parameters in neurodegenerative dementias characterized by low and high A beta loads.Methods: M1 receptors, M1 coupling to G-proteins as well as A beta were measured in postmortem frontal cortex of a cohort of longitudinally assessed patients with Parkinson's Disease Dementia (PDD, low A beta load) and AD with significant subcortical cerebrovascular disease (AD + CVD, high A beta load). Results: We found unchanged levels of M1 receptors in both dementia groups, while M1 coupling was reduced only in AD + CVD (p < 0.01). Furthermore, A beta concentration was significantly increased only in AD + CVD, and correlated negatively with M1-G-protein coupling in the dementia groups.Conclusions: Our study suggests that loss ofM1coupling to G-proteins may be a neurochemical feature of neurodegenerative dementias with high cortical A beta burden, and that cholinergic replacement therapies may be more efficacious for PDD due to low A beta burden.


Publication metadata

Author(s): Lee JH, Francis PT, Ballard CG, Aarsland D, Kalaria RN, Wong PTH, Chen CP, Lai MKP

Publication type: Article

Publication status: Published

Journal: Journal of Parkinsons Disease

Year: 2016

Volume: 6

Issue: 4

Pages: 733-739

Online publication date: 19/10/2016

Acceptance date: 13/09/2016

ISSN (print): 1877-7171

ISSN (electronic): 1877-718X

Publisher: IOS Press

URL: http://dx.doi.org/10.3233/JPD-160932

DOI: 10.3233/JPD-160932


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Alzheimer's Research UK
Alzheimer's Society
London Neurodegenerative Diseases Brain Bank - MRC
NIHR Newcastle Biomedical Research Centre and Unit
G0400074UK Medical Research Council
NMRC/CSA/032/2011National Medical Research Council in Singapore

Share